| GIP | gastric inhibitory polypeptide; giant cell interstitial pneumonia; glucose-dependent insulinotropic ... |
|---|---|
| GIPR | gastric inhibitory polypeptide receptor |
| GIP | 1) Giant cell Interstitial Pneumonia 2) Gastric Inhibitory (Poly)Peptide |
| GA | Gamblers Anonymous; gastric analysis; gastric antrum; general anesthesia; general angiography; gener... |
| GF | gastric fistula; gastric fluid; germ-free; glass factor; glomerular filtration; gluten-free; grandfa... |
| GIP | Gastric Inhibitory Polypeptide |
|---|---|
| IR-GIP | Immunoreactive gastric inhibitory polypeptide |
| GIP | Gastric Inhibitory Peptide |
| alpha-hANP | Alpha human atrial natriuretic polypeptide |
| ANP | Atrial Natriuretic Polypeptide |
| gastric inhibitory polypeptide | <hormone> Peptide hormone (43 amino acids) that stimulates insulin release and inhibits the release of gastric acid and pepsin. Acronym: GIP (18 Nov 1997) |
|---|
| basic polypeptide-activated protein kinase | <enzyme> Requires mn2+ for its activity; from bombyx mori; does not require cyclicamp, cyclicgmp or ca Registry number: EC 2.7.1.- Synonym: ba kinase (26 Jun 1999) |
|---|---|
| vasoactive intestinal polypeptide | A polypeptide hormone secreted most commonly by non-beta islet cell tumours of the pancreas, producing copious watery diarrhoea and faecal electrolyte loss, particularly hypokalaemia; VIP increases the rates of glycogenolysis; stimulates pancreatic bicarbonate secretion. Synonym: vasoactive intestinal peptide. (05 Mar 2000) |
| pancreatic polypeptide | <chemical> A 36-amino acid polypeptide with physiological regulatory functions. It is secreted by pancreatic tissue. Plasma pancreatic polypeptide increases after ingestion of food, with age, and in disease states. A lack of pancreatic polypeptide in the islets of langerhans has been associated with the obese syndrome in rats and mice. Chemical name: Pancreatic polypeptide (12 Dec 1998) |
| photosystem II D1 polypeptide carboxy-terminal processing protease | <enzyme> From thylakoids; not inhibited by common protease inhibitors Registry number: EC 3.4.99.- Synonym: d1 carboxy-terminal processing protease, d1 c-terminal protease, ctpa gene product (26 Jun 1999) |
| polypeptide | <biochemistry> A peptide which on hydrolysis yields more than two amino acids, called tripeptides, tetrapeptides, etc. According to the number of amino acids contained. (14 Oct 1997) |
| polypeptide fucosyltransferase | <enzyme> From cho cells; attaches fucose through an o-glycosidic linkage to serine or theonine in egf domains Registry number: EC 2.4.1.- Synonym: GDPfucose - polypeptide fucosyltransferase (26 Jun 1999) |
| polypeptide N-acetylgalactosominyltransferase | <enzyme> N-acetylgalactosaminyl residue is transferred to threonine or serine hydroxyl groups Registry number: EC 2.4.1.41 Synonym: protein-udpacetylgalactosaminyltransferase, udp-n-acetylgalactosamine mucin transferase, udp-n-acetylgalactosamine-polypeptide n-acetylgalactosamine transferase, udpacetylgalactosamine-protein acetylgalactosaminyltransferase, udp-gpagat, udp-galnac-polypeptide, n-acetylgalactosaminyltransferase, galnac-transferase, udp-galnac-polypeptide n-acetylgalactosaminyltransferase (26 Jun 1999) |
| tissue polypeptide antigen | Serological tumour marker composed of a molecular complex of cytokeratins 8, 18, and 19. It is used in the diagnosis and staging of bronchogenic carcinoma. (12 Dec 1998) |
| trefoil polypeptide | A group of polypeptides that share the trefoil moiety of a highly stable three-loop structure held together by disulfide bonds based on cysteine residues; they are widely expressed in gastrointestinal tissues and secreted by mucous cells; their functions are as yet unknown. (05 Mar 2000) |
| macrophage migration-inhibitory factors | Proteins released by sensitised lymphocytes and possibly other cells that inhibit the migration of macrophages away from the release site. The structure and chemical properties may vary with the species and type of releasing cell. (12 Dec 1998) |
| G-protein, inhibitory GI | A g-protein that inhibits adenylyl cyclase and activates k+ channels. (12 Dec 1998) |
| migration-inhibitory factor | <growth factor> A soluble, nondialysable factor that is produced by sensitised lymphocytes following exposure to a specific antigen. It inhibits macrophage migration and causes adherence. It was originally defined on the basis of inhibition of emigration of mononuclear cells from capillary (haematocrit) tubes, more recently a 13 kD protein with migration inhibitory activity has been isolated. Acronym: MIF Synonym: inhibition factor. (22 Sep 2002) |
| migration-inhibitory factor test | A test which measures the presence of migration-inhibitory factor. Usually peritoneal macrophages are placed in a capillary tube in the presence or absence of supernatants from activated T-cells. If MIF is present, the migration of monocyte/macrophages is reduced. Synonym: macrophage migration inhibition test, migration inhibition test. (05 Mar 2000) |
| minimal inhibitory concentration | <microbiology, pharmacology> The lowest concentration of antibiotic sufficient to inhibit bacterial growth when tested in vitro. (05 Mar 2000) |
| inhibitory | Of or pertaining to, or producing, inhibition; consisting in inhibition; tending or serving to inhibit; as, the inhibitory action of the pneumogastric on the respiratory center. "I would not have you consider these criticisms as inhibitory. <physiology> " (Lamb) Inhibitory nerves, those nerves which modify, inhibit, or suppress a motor or secretory act already in progress. Origin: LL. Inhibitorius: cf. F. Inhibitoire. Source: Websters Dictionary (01 Mar 1998) |
Synonyms : Gastric-Inhibitory Polypeptide, Glucose Dependent Insulinotropic Peptide, Glucose-Dependent Insulin-Releasing Peptide, Glucose Dependent Insulin Releasing Peptide, Inhibitory Polypeptide, Gastric, Insulin-Releasing Peptide, Glucose-Dependent
| gastric inhibitory polypeptide |
(GIP) glucose-dependent insulinotropic polypeptide, a polypeptide hormone (molecular weight 5165; 43 amino acids) synthesized by K cells in the midzone of the duodenal and jejunal mucosa and released in response to oral glucose, fat, or amino acids; it is a potent insulin stimulant, increases insulin secretion, and inhibits gastric secretion and motility.
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|